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Abstract
Background: Due to the rising use of nanomaterials (NMs), there is concern that NMs induce undesirable
biological effects because of their unique physicochemical properties. Recently, we reported that amorphous silica
nanoparticles (nSPs), which are one of the most widely used NMs, can penetrate the skin barrier and induce
various biological effects, including an immune-modulating effect. Thus, it should be clarified whether nSPs can be
a risk factor for the aggravation of skin immune diseases. Thus, in this study, we investigated the relationship
between the size of SPs and adjuvant activity using a model for atopic dermatitis.
Results: We investigated the effects of nSPs on the AD induced by intradermaly injected-mite antigen
Dermatophagoides pteronyssinus (Dp) in NC/Nga mice. Ear thickness measurements and histopathological analysis
revealed that a combined injection of amorphous silica particles (SPs) and Dp induced aggravation of AD in an SP
size-dependent manner compared to that of Dp alone. In particular, aggravation was observed remarkably in nSP-
injected groups. Furthermore, these effects were correlated with the excessive induction of total IgE and a stronger
systemic Th2 response. We demonstrated that these results are associated with the induction of IL-18 and thymic
stromal lymphopoietin (TSLP) in the skin lesions.
Conclusions: A particle size reduction in silica particles enhanced IL-18 and TSLP production, which leads to
systemic Th2 response and aggravation of AD-like skin lesions as induced by Dp antigen treatment. We believe
that appropriate regulation of nanoparticle physicochemical properties, including sizes, is a critical determinant for
the design of safer forms of NMs.
Keywords: Nanoparticle, Silica, Allergy, Cytokines
Background
With the development of nanotechnology, practical uses
for nanomaterials (NMs) are rapidly spreading to a wide
variety of fields, such as cosmetics, food, and medicine,
because they have unique physicochemical properties and
exert innovative functions [1-3]. These observations mean
that intentional exposure of NMs is unavoidable in every-
day life. However, it is a concern that NMs can exhibit
unknown harmful effects [4,5]. For example, maternal
exposure to titanium dioxide nanoparticles (nTiO2)
induces gene expression alterations related to brain devel-
opment [6]. We also revealed that amorphous silica nano-
particles (nSPs) and nTiO2 induce reproductive and/or
liver toxicity compared with submicron-sized amorphous
silica particles (SPs) [7,8]. However, little information
exists on the potential hazard of NMs. To ensure the
safety of NMs and enjoy their many benefits, it is essential
to obtain more information on the relationship between
the factors associated with NM hazards and their physico-
chemical properties, such as size and surface properties, to
design safer forms of NMs.
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nSPs are used as a base material in cosmetics and an
anti-caking agent in food because of their high trans-
parency and coatability [9,10]. Because nSPs are one of
the most widely used NMs, the chances of being
exposed to nSPs in our daily life are high. Thus, we
must analyze the in vitro/in vivo biodistribution of
nSPs including estimations of whether they can pene-
trate the biological barrier. Additionally, we need to
estimate whether they could be responsible for acute/
chronic side effects, thereby facilitating a more accu-
rate risk analysis of nSPs. Under these circumstances,
we revealed that nSPs with a diameter of 70 nm
(nSP70) can penetrate the skin barrier and enter kera-
tinocytes and Langerhans cells [11]. Our studies
further revealed that a dermal application of nSP70
induces apoptosis in dermal cells [11]. In addition, we
reported that nSPs have a greater cytotoxic effect on
Langerhans cells [12]. Thus it is possible that nSPs
may be associated with development of the allergic dis-
eases such as atopic dermatitis (AD). However, the
relationship between the size of SPs and its adjuvant
activity which can affect aggravation of AD like skin
lesion has remained unclear.
In present study, we investigated the effect of nSPs on
AD-like skin lesions using Dermatophagoides pteronyssi-
nus (Dp), which is the main allergen of AD [13], in NC/
Nga mice. We also examined the relationship between
the SP size and aggravation of AD.
Results
Physicochemical properties of variously sized SPs
Prior to undertaking this study, we first analyzed the
physicochemical properties of SPs (Table 1). SPs
remained as stable well-dispersed particles in PBS and
not as aggregates. Thus, these particles were ideally sui-
ted to evaluate whether their biological effects depended
on particle size.
Effects of variously sized SPs on AD-like skin lesions
To evaluate whether variously sized SPs affects AD-like
skin lesions induced by Dp, we first measured ear
thickness on days 0 and 19. We confirmed that the
intradermal injection of Dp enhanced ear thickening as
compared to that of PBS (Figure 1A). A combined injec-
tion of Dp and the submicron-sized SPs, mSP1000 or
nSP300, did not enhance ear thickening compared with
that of Dp alone. In contrast, a combined injection of
Dp + nSPs (nSP100, nSP70, and nSP30) enhanced ear
thickening two- to fivefold compared with that of Dp
alone. nSP-treatment showed a marked tendency to
cause ear thickening. Thus, nSPs with a diameter ≤100
nm acted specifically to enhance ear thickening in this
model.
Next, we performed hematoxylin-eosin and toluidine
blue staining using ear sections 24 h after the last intra-
dermal injection (Figure 1B and 1D). Then, several
representative symptoms (scab, acanthosis, inflammatory
cell infiltration, and scleredema) were scored on the
H&E sections (Figure 1C). A Dp injection caused signifi-
cant inflammatory cell infiltration compared with a PBS
injection. In contrast, a combined injection of Dp and
variously sized SPs caused more severe inflammatory
cell infiltration than that of Dp alone. Although the Dp
injection did not cause scabs, acanthosis, or scleredema,
the combined injection of Dp and SPs with a diameter
≤300 nm caused acanthosis. Furthermore, a combined
injection of Dp and nSPs caused significant scabs and
scleredema (Figure 1C). Mast cell infiltrates in the skin
were stronger following the combined injection of Dp
and nSPs (Figure 1D and 1E). Thus, the injection of Dp
and submicron-sized SPs caused only inflammatory cell
infiltration and acanthosis compared with that of Dp
alone. However, injecting Dp and nSPs caused not only
inflammatory cell infiltration and acanthosis but also
scabs and scleredema. These findings suggest that inject-
ing nSPs with a diameter ≤100 nm and Dp induced
severe AD-like histological changes.
Effects of variously sized SPs on the IgE response
Many reports have shown that the total IgE and aller-
gen-specific IgE level correlate with severity of AD
[14,15]. To clarify the nSP-mediated aggravation of AD-
like lesions, we first measured total IgE and Dp-specific
IgE 24 h after the last intradermal injection (Figure 2).
The total IgE in the Dp alone group was higher than
that in the PBS group (Figure 2A). Furthermore, the
levels of total IgE in the Dp + SP groups were enhanced
in an SP size-dependent manner compared with those
in the Dp alone group. A regression analysis showed
that the particle size reduction was a significant contri-
butor to this effect (Figure 2B; R2 = 0.98). Therefore, it
paralleled the severity of the AD-like skin lesions. In the
presence of variously sized SPs, the Dp-specific IgE
levels were significantly increased compared with Dp
alone group (Figure 2C). However, Dp-specific IgE levels
Table 1 Summary of the physicochemical properties of








mSP1000 1000 1136 ± 32.1 -33.2 ± 1.4 7.6
nSP300 300 264 ± 7.2 -25.8 ± 0.7 7.4
nSP100 100 106 ± 0.6 -24.3 ± 0.5 7.4
nSP70 70 76 ± 1.7 -19.5 ± 1.0 7.4
nSP30 30 39 ± 4.2 -14.0 ± 1.3 7.4
Mean particle size and zeta potential in solution of silica particles are
expressed as mean ± S.D. (n = 3). a Information from technical datasheet of
products.
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Figure 1 Effects of amorphous silica nanoparticles (nSPs) on atopic dermatitis (AD)-like skin lesions induced by Dermatophagoides
pteronyssinus (Dp). NC/Nga mice were intradermally injected on the ventral side of both ears with Dp alone or Dp plus SPs in PBS on days 1,
3, 5, 7, 9, 11, 13, 16, and 18. Ear thickness was measured on days 0 and 19 (A). The ears were removed 24 h after the last intradermal injection.
Sections were prepared, and the ears were stained with H&E to assess representative symptoms of AD (B and C) or with toluidine blue to assess
mast cell infiltration (D and E). Representative histological findings of the PBS, Dp, Dp + mSP1000, and Dp + nSP30 groups are shown. Several
representative symptoms of AD were scored in the H&E sections (C). Infiltration of mast cells was evaluated as the number of cells in toluidine
blue sections in a high power field (E). Data are presented as mean ± SE of 4-5 animals per group. The results are representative of two separate
experiments. *P < 0.05 vs. Dp group. Scale bars: 100 μm (B) and 50 μm (D).
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were not paralleled with the size of SPs. Thus, nSP-
mediated aggravation of AD-like lesions has more to do
with total IgE than Dp-specific IgE.
Cytokine expression analysis of nSP-injected skins
To clarify the mechanism of AD-like skin lesions
enhanced by SPs, we analyzed the cytokine expression
profile in the skin related to Dp. We examined the levels
of Th2-type cytokines (IL-4, IL-5, and IL-13), Th1-type
cytokines IFN-g, IL-18, and thymic stromal lymphopoie-
tin (TSLP) in the ears 24 h after the last intradermal
injection (Figure 3). Intradermal injection of Dp alone
increased the local expression of IL-4 and IL-13 and
decreased the production of IL-5 and IFN-g compared
with PBS injection. Only differences of the expression of
IL-13 between the Dp group and PBS group is signifi-
cant. In contrast, the level of IL-4 in the Dp + SP
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Figure 2 Effects of amorphous silica particles (SPs) on total and Dermatophagoides pteronyssinus (Dp)-specific IgE production in
plasma. NC/Nga mice were intradermally injected on the ventral side of both ears with Dp alone or Dp plus SPs in PBS on days 1, 3, 5, 7, 9, 11,
13, 16, and 18. To evaluate AD severity, plasma was collected 24 h after the last intradermal injection and analyzed by ELISA for total and Dp-
specific IgE (A and C). A regression analysis of total IgE was also performed (B). Data are presented as mean ± SE of 4-5 animals per group. The
results are representative of two separate experiments. *P < 0.05 vs. Dp group.
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Figure 3 Analysis of the local immune response induced by Dermatophagoides pteronyssinus (Dp) + amorphous silica particles (SPs).
NC/Nga mice were intradermally injected on the ventral side of both ears with Dp alone or Dp plus SPs in PBS on days 1, 3, 5, 7, 9, 11, 13, 16,
and 18. At 24 h after the last intradermal injection, the ears were removed and homogenized. The homogenates were centrifuged at 10,000 rpm
for 5 min, and the supernatants were collected. The levels of interleukin (IL)-4, IL-5, IL-13, interferon (IFN)-g, IL-18, and thymic stromal
lymphopoietin (TSLP) in the supernatants were examined by ELISA (A, B, and D). A regression analysis of IL-18 was also performed (C). Data are
presented as mean ± SE of 4-5 animals per group. The results are representative of two separate experiments. *P < 0.05 vs. Dp group.
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compared with that in the Dp alone group. The levels of
IL-5 and IL-13 in the Dp + SP groups with a diameter
≤300 nm decreased significantly compared with those in
the Dp alone group. Additionally, injections of SPs with
a diameter ≤300 nm led to a significant decrease in
IFN-g compared to those of Dp alone (Figure 3A). Thus,
the injection of SPs with Dp tended to enhance the
effects of injecting Dp alone in terms of cytokine levels
in the skins. However, the levels of IFN-gammma and
IL-5 were significantly reduced after SPs treatment
when compared to Dp only. The levels of IL-18, known
as an AD-inducing cytokine, were higher in the Dp +
smaller SP groups than those in the Dp alone group
(Figure 3B). A regression analysis showed that the parti-
cle size reduction was a significant contributor to this
effect (Figure 3C; R2 = 0.91). IL-18 production size-
dependently increased similar to that of plasma total IgE
levels. Furthermore, the levels of TSLP, an AD-inducing
cytokine, were enhanced in only the Dp + nSP groups
compared with those in the Dp alone group (Figure
3D). This result matched that of increase in ear
thickness.
Dp-specific immune response in Dp + SPs-injected mice
To evaluate the effect of SPs on systemic immune
responses, we examined the levels of Dp-specific IgG
and its subtypes by ELISA 24 h after the last intrader-
mal injection (Figure 4A and 4B). Higher levels of Dp-
specific IgG were observed in the Dp + SP groups than
those in the Dp alone group (Figure 4A). Furthermore,
higher Dp-specific IgG levels were observed, particularly
in Dp + nSP groups. Dp-specific IgG1 levels in the Dp
+ SP groups were higher than those in the Dp alone
groups. In contrast, the levels of Dp-specific IgG2a were
low in all groups except the Dp + nSP30 group. Plasma
IgG subclass responses have been used to assess the
type of immune response. It is well-known that IgG1 is
indicative of a Th2-type response, whereas IgG2a is
indicative of a Th1 response. Therefore, these results
indicate that Dp + SPs induced antigen-specific Th2-
type immune responses and that Dp + nSP30 induced
not only Th2-type immune responses but also Th1-type
responses.
To further characterize the type of systemic immune
response, we measured the levels of Dp-specific IFN-g-
and IL-4-secreting splenocytes from each intradermally
injected mouse using a cytokine-specific ELISPOT assay
(Figure 4B). The number of Dp-specific IFN-g-secreting
splenocytes in the Dp + nSP30 group was significantly
greater than that in all other groups. However, no differ-
ence was observed in the Dp-specific IFN-g-secreting
splenocytes of all groups except the Dp + nSP30 group.
These levels of Dp-specific IFN-g-secreting splenocytes
were correlated with Dp-specific IgG2a levels. The levels
of Dp-specific IL-4-secreting splenocytes in the Dp + SP
groups were enhanced in a SP size-dependent manner
compared with those in the Dp alone group (Figure 4C).
The regression analysis showed that the particle size
reduction was a significant contributor to this effect
(Figure 4D; R2 = 0.93). Thus, the levels of Dp-specific
IL-4-secreting splenocytes paralleled AD severity.
Discussion
The lifetime prevalence of AD is estimated at 15-30% in
children and 2-10% in adults, and the incidence of AD
has increased by two- to threefold during the past three
decades in industrialized countries [16,17]. Although
environmental factors and lifestyle changes are specu-
lated to be associated with the increased number of
patients with AD, the detailed relationships between
environmental factors or lifestyle changes and the
increase in AD are not well understood. Some epide-
miological studies have shown that chronic exposure to
urban fine particles could be a risk factor for AD
[18,19]. In addition, nTiO2 and polystyrene nanoparti-
cles have been reported to exacerbate AD [20,21]. Thus,
among other environmental factors, NMs may be a risk
factor for the onset or aggravation of AD. However, the
relationship between AD and nSPs, which are one of the
most widely used NMs in various applications, has never
been investigated. Here, to clarify the relationship
between NM use and the onset or aggravation of AD,
we investigated the effects of nSPs on AD-like skin
lesions induced by a mite allergen Dp.
Typical symptoms of AD, such as inflammation or
itching of the skin, are induced by chemical mediators
such as histamine and some cytokines [22,23]. Further-
more, these chemical mediators or cytokines are
induced by IgE or antigen cross-linking of IgE bound to
FcεRI on mast cells [24]. We measured Dp-specific IgE
to determine allergen-specific IgE participation in the
aggravation of AD. As expected, the Dp-specific IgE
level was higher in the Dp + SP groups than that in the
Dp alone group (Figure 2C). Because particle materials
influence the intracellular processing of antigen in anti-
gen-presenting cells (APCs) such as dendritic cells
(DCs) [25,26], it is possible that SPs affected these APCs
and changed the Dp-specific immune responses. How-
ever, these Dp-specific IgE levels were not dependent on
SP size and were not high in the Dp + nSP groups com-
pared with those in the Dp + submicron-sized SPs
groups. In contrast, a regression analysis showed that
the total IgE levels, which are known to correlate with
AD severity [27,28], were completely dependent on
injected SP size (Figure 2A; R2 = 0.98). Thus, this result
suggested that smaller SPs induced more severe AD
and, most importantly, that the mechanisms of AD
aggravation caused by SPs were induced not only by
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Dp-specific IgE. Thus, the mechanisms different from
the mechanisms correlated with Dp-specific IgE produc-
tion were also involved in this model. Therefore, clarifi-
cation of the mechanisms of size-dependent aggravation
of AD-like skin lesions is important for a risk analysis of
nSPs and for designing safer forms of nSPs.
AD skin lesions are characterized by recruitment of
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Figure 4 Analysis of the systematic immune response induced by Dermatophagoides pteronyssinus (Dp) + amorphous silica particles
(SPs). NC/Nga mice were intradermally injected on the ventral side of both ears with Dp alone or Dp plus SPs in PBS on days 1, 3, 5, 7, 9, 11,
13, 16, and 18. At 24 h after the last intradermal injection, splenocytes and plasma were collected from each group. Dp-specific IgG and its
subclasses (A) in plasma were analyzed by ELISA. Splenocytes from each group were cultured with 100 μg ml-1 Dp. The levels of Dp-specific
interferon (IFN)- g and interleukin (IL)-4-producing cells were examined by individual cytokine-specific ELISPOT assay (B). A regression analysis of
Dp-specific IL-4-producing cells was also performed (C). Data are presented as mean ± SE of 4-5 animals per group. The results are
representative of two separate experiments. *P < 0.05 vs. Dp group.
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[29,30]. These infiltrating cells produce Th2 cytokines
including IL-4 and IL-13. These mediators promote Th2
deviation not only in acute eczematous skin lesions but
also in systemic adaptive immune systems [31,32]. This
Th2 deviation could further compromise barrier func-
tion in the skin lesions and complete a potential out-
side-inside-outside pathogenic loop of AD [33].
Additionally, IL-18 or TSLP plays a critical role in the
spontaneous development of AD [34,35]. Considering
this, we first performed an analysis of the Th1/Th2
cytokine balance in the skin lesions to clarify the
mechanism of AD aggravation by SPs. Although IL-4
levels in the ears increased, IL-5, IL-13, and IFN-g levels
decreased following exposure to Dp + SPs compared
with those following exposure to Dp alone (Figure 3).
There is possible that variously sized SPs induced the
expression of Th2 cytokines at an early phase and that
this induction might contribute to the aggravation of
symptoms. A time-course study is needed to elucidate
the correlation between symptoms and inflammatory
mediators.
Epithelial cells are major cell source of various pro-
allergic cytokines, such as IL-18 and TSLP. As they are
accumulated preferentially in the inflammatory sites of
patients with AD, IL-18 and TSLP might be involved in
the development of AD [16,36]. To reveal the mechnisms
of the nSPs-mediated aggravation of AD-like skin lesion,
we performed further analyses to measure IL-18 and
TSLP levels in the skin. Interestingly, the IL-18 levels in
skin lesions of the Dp + SP groups increased compared
to those in the Dp alone group in a SP size-dependent
manner (Figure 3; R2 = 0.91). IL-18 is a cytokine that sti-
mulates mast cells and basophils to release AD-asso-
ciated molecules, Th2 cytokines, and histamine, without
a pathway that involves Ag, IgE, or FcRI. Furthermore,
IL-18 induces large amounts of total IgE via natural killer
T and CD4+ T cells [37-39]. These effects of IL-18 finally
induce AD-like skin lesions [34]. Considering these, this
IL-18 production in a size-dependent manner of SPs
show why smaller SPs induced severe AD accompany the
production of total IgE. On the other hands, the TSLP
levels were only increased following the exposure to Dp
+ “nSPs” (Figure 3). This result is similar to those of
increase in ear thickness, scab and scleredema. TSLP can
promote the Th2 cytokine-associated inflammation by
directly promoting the effector functions of CD4+ Th2
cells, basophils and other granulocyte populations via DC
[35,40]. Furthermore, it is reported that skin-specific
overexpression of TSLP resulted in an AD-like skin
lesion [35,40]. Thus, these results suggested that TSLP as
well as IL-18 might be involved in the development of
nSP-mediated AD-like skin lesions in mice. Although we
need further mechanistic studies for understanding the
nSP-mediated production of IL-18 and TSLP,
modification of physicochemical nSPs properties for sup-
pressing IL-18 or TSLP production might be value in the
development of safer NMs.
On the other hands, we observed that only treated
with nSP70 did not change pathology and local immune
responses compared with PBS treated mouse except IL-
18 productions (our preliminary data). However only IL-
18 production was tendency to be enhanced by treat-
ment with only silica nanoparticles, the enhancement of
IL-18 productions are very slightly (not significant).
Thus, we think the evoked inflammation in the ear was
mainly attributed to the mixture of nSPs and Dp. There-
fore we also must give attention to the interactions of
nSPs with antigen to develop of safer NMs.
Conclusions
In this study, we showed the intradermal injections of
SPs and Dp antigen aggravate AD-like skin lesions in
size dependent manner. We speculated that particle size
affects SPs-induced IL-18 and TSLP inductions enhance
the Th2 immune responses related to Dp and then
induce aggravation of AD-like skin lesions. On the other
hands, the further studies are required to analyze the
mechanisms why IL-18 and TSLP are induced by nSPs.
Furthermore, the studies are also required to investigate
whether SPs are the risk factor of AD using topical
applications of SPs, which is a more likely mode of
exposure to NMs. Considering the fact that the nSPs
already used in general are smaller than our used ones,
our results demand a careful hand. We consider that
appropriate regulation of physical and chemical proper-
ties of nanoparticles, including sizes mediated by the
inductions of IL-18 and TSLP are critical determinants
for the design of safer forms of NMs.
Methods
SPs
Suspensions of SPs (Micromod Partikeltechnologie
GmbH, Rostock, Germany) (25 and 50 mg ml-1 in
water) were used; particle size diameters were 1000,
300, 100, 70, and 30 nm (designated as mSP1000,
nSP300, nSP100, nSP70, and nSP30, respectively). These
SPs don’t have any coating. SP suspensions were stored
at room temperature. The suspensions were sonicated
in power of 400 W for 5 min at 25°C and then vortexed
for 1 min immediately prior to use.
Mice
Male NC/Nga slc mice were purchased from Nippon
SLC (Kyoto, Japan) and used at 8 weeks of age. We
used n = 4 or 5 animals per each assay. All animal
experimental procedures were performed in accordance
with the institutional ethical guidelines for animal
experiments.
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Physicochemical examination of SPs
SPs were diluted to 0.25 mg ml-1 (nSP30 and nSP70) or
0.5 mg ml-1 (nSP100, nSP300, and mSP1000) with PBS
(Sigma-Aldrich, St. Louis, MO, USA), and the average
particle size and zeta potential were measured using a
Zetasizer Nano-ZS (Malvern Instruments Ltd., Worces-
tershire, UK) at 25°C. The mean size and size distribu-
tion of SPs were measured using the dynamic light
scattering method. The zeta potential was measured by
laser Doppler electrophoresis. We perform these mea-
surements using Size and Zeta capillary cell (Malvern
Instruments Ltd). The pH of each particle suspension
was measured with an ISFET pH meter (Shindengen,
Tokyo, Japan).
Study protocols
Mice were divided into seven experimental groups (4 or
5 mice were used in each group): PBS, Dp, Dp +
mSP1000, Dp + nSP300, Dp + nSP100, Dp + nSP70,
and Dp + nSP30 groups. The PBS group received 20 μl
of PBS. The Dp group received 2.5 μg of Dp mite aller-
gen extract (Cosmo Bio LSL, Tokyo, Japan) in 20 μl
PBS. The Dp + mSP1000, Dp + nSP300, Dp + nSP100,
Dp + nSP70, and Dp + nSP30 groups received a com-
bined administration of 2.5 μg Dp and 250 μg SPs
(1000, 300, 100, 70, or 30 nm) in 20 μl PBS. Mice were
intradermally injected on the ventral side of both their
ears with Dp alone or Dp plus SPs in PBS on days 1, 3,
5, 7, 9, 11, 13, 16, and 18 under anesthesia with pento-
barbital (somnopentyl; Kyouritsuseiyaku, Tokyo, Japan).
The amount of injected liquid was 10 μl per ear. We
measured ear thickness on days 0 and 19.
Histological analysis
At 24 h after the last intradermal injection, the ears of
mice were removed and placed in fixative solution (4%
paraformaldehyde in PBS; Wako, Osaka, Japan). A histo-
pathological examination was performed by the Applied
Medical Research Laboratory (AMRL; Osaka, Japan).
Several representative symptoms (scab, acanthosis,
inflammatory cell infiltration, and scleredema) observed
in the AD of each sample were scored as 0 (none), 1
(very mild), 2 (mild), 3 (moderate), or 4 (severe). Scoring
was also performed by AMRL, who was unaware of the
treatment assignments. Mast cell numbers in three
high-power fields at ×400 magnification were selected
randomly and counted.
Blood sampling
Mice were anesthetized with pentobarbital 24 h after the
last intradermal injection. The chest and abdominal
walls were opened, and blood was sampled by cardiac
puncture. Then blood was centrifuged at 3000 g at 4°C
and we obtained plasma. Plasma was stored at -80°C
until assay.
Quantitation of total IgE Abs
Total IgE in plasma was measured with an ELISA assay
kit (BD Biosciences, San Diego, CA, USA) according to
the manufacturer’s instructions.
Detection of Dp-specific Ab by ELISA
Antigen-specific Ab levels in plasma were determined by
ELISA. ELISA plates (Maxisorp, type 96F; Nunc A/S,
Roskilde, Denmark) were coated with 100 μg ml-1 Dp in
coating buffer PBS and incubated overnight at 4°C. The
plates were washed with PBS-Tween20, incubated with
blocking solution (Block Ace; Dainippon Sumitomo
Pharmaceuticals, Osaka, Japan) at room temperature
(RT) for 2 h, and plasma dilutions were added to the
antigen-coated plates. After a 2-h RT incubation, the
coated plates were washed with PBS-Tween20 and incu-
bated with a HRP-conjugated goat anti-mouse IgG or
IgG1 solution or a biotin-conjugated goat anti-mouse
IgG2a or IgE detection Ab solution (Southern Biotech-
nology Associates, Birmingham, AL, USA) at RT for 2
h. To detect IgG2a or IgE, the plates were washed with
PBS-Tween20 and then incubated with HRP-coupled
streptavidin (Southern Biotechnology Associates) for 30
h at RT. After the incubation, the color reaction was
developed with tetra methyl benzidine (MOSS, Inc.;
Pasadena, MD, USA), stopped with 2 N H2SO4, and
measured at OD450-620 on a microplate reader.
Isolation of splenocytes
Spleens were aseptically removed and placed in RPMI
1640 (Wako) supplemented with 10% FBS, 10 ml L-1 of
a 100 × nonessential amino acid solution (Gibco, Invi-
trogen, Carlsbad, CA, USA), 50 μM 2-mercaptoethanol
(Gibco), and 1% antibiotic cocktail (Pennicilin; 10000 U/
mL, Streptomycin; 10000 μg/mL, amphotericin B; 25
μg/mL) (Gibco). A single-cell suspension of splenocytes
was treated with ammonium chloride to lyse the red
blood cells, which were washed, counted, and suspended
in RPMI 1640 to a final concentration of 1 × 107 cells
ml-1.
ELISPOT assay
An ELISPOT assay was performed to detect interferon
(IFN)- g and IL-4 producing cells. Dp-specific cytokine
responses were evaluated by culturing the splenocytes (5
× 105 cells well-1) stimulated with Dp (100 μg ml-1) in
vitro. After a 24-h incubation at 37°C, the plate was
washed, and the IFN-g- and IL-4-producing cells were
measured with an ELISPOT assay kit (BD Biosciences)
according to the manufacturer’s instructions.
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Quantitation of cytokine protein levels in ear tissue
supernatants
At 24 h after the last intradermal injection, mice ears
were removed and stored at -80°C. Later, the ears were
homogenized with cell extraction buffer (Invitrogen).
The homogenates were then centrifuged at 10,000 rpm
for 5 min, and the supernatants were stored at -30°C.
ELISAs for IFN-g (BD Biosciences), IL-4, IL-5, IL-13
(eBioscience, San Diego, CA, USA), IL-18 (MBL,
Nagoya, Japan), and thymic stromal lymphopoietin
(TSLP; R&D Systems, Minneapolis, MN, USA) in the
ear tissue supernatants were performed according to the
manufacturer’s instructions.
Statistical analysis
All data are presented as mean ± SE. The significant dif-
ferences among groups were determined by ANOVA.
Differences between the experimental groups and the
control group were determined by Williams’ test. P <
0.05 was considered significant.
Acknowledgements
This study was supported, in part, by Grants-in-Aid for Scientific Research
from the Ministry of Education, Culture, Sports, Science and Technology of
Japan (MEXT) and from the Japan Society for the Promotion of Science
(JSPS); and by the Knowledge Cluster Initiative (MEXT); by Health Labour
Sciences Research Grants from the Ministry of Health, Labour and Welfare of
Japan (MHLW); by a Global Environment Research Fund from the Ministry of
the Environment; by Food Safety Commission (Cabinet Office); by The
Cosmetology Research Foundation; by The Smoking Research Foundation;
and by The Takeda Science Foundation.
Author details
1Laboratory of Toxicology and Safety Science, Graduate School of
Pharmaceutical Sciences, Osaka University, 1-6, Yamadaoka, Suita, Osaka 565-
0871, Japan. 2Laboratory of Biopharmaceutical Research (Pharmaceutical
Proteomics), National Institute of Biomedical Innovation, 7-6-8, Saito-Asagi,
Ibaraki, Osaka 567-0085, Japan. 3The Center for Advanced Medical
Engineering and Informatics, Osaka University, 1-6, Yamadaoka, Suita, Osaka
565-0871, Japan.
Authors’ contributions
TH and TY designed the study; TH, HN, TY, S. Tochigi, KI, MU and TA
performed experiments; TH and TY collected and analyzed data; TH and TY
wrote the manuscript; KN, YA, YY, HK, NI and S. Tsunoda gave technical
support and conceptual advice. YT supervised the all of projects. All authors
discussed the results and commented on the manuscript. All authors have
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 21 September 2011 Accepted: 2 February 2012
Published: 2 February 2012
References
1. Bowman DM, van Calster G, Friedrichs S: Nanomaterials and regulation of
cosmetics. Nat Nanotechnol 2010, 5:92.
2. Liu D, Gu N: Nanomaterials for fresh-keeping and sterilization in food
preservation. Recent Pat Food Nutr Agric 2009, 1:149-154.
3. Salata O: Applications of nanoparticles in biology and medicine. J
Nanobiotechnology 2004, 2:3.
4. Choksi AN, Poonawalla T, Wilkerson MG: Nanoparticles: a closer look at
their dermal effects. J Drugs Dermatol 2010, 9:475-481.
5. Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel.
Science 2006, 311:622-627.
6. Shimizu M, Tainaka H, Oba T, Mizuo K, Umezawa M, Takeda K: Maternal
exposure to nanoparticulate titanium dioxide during the prenatal period
alters gene expression related to brain development in the mouse. Part
Fibre Toxicol 2009, 6:20.
7. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K: Silica
nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 2009, 72:496-501.
8. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M,
Yoshida T, Ogura T, Nabeshi H, Nagano K, et al: Silica and titanium dioxide
nanoparticles cause pregnancy complications in mice. Nat Nanotechnol
2011, 6:321-328.
9. Knopp D, Tang D, Niessner R: Review: bioanalytical applications of
biomolecule-functionalized nanometer-sized doped silica particles. Anal
Chim Acta 2009, 647:14-30.
10. Martin KR: The chemistry of silica and its potential health benefits. J Nutr
Health Aging 2007, 11:94-97.
11. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A,
Isobe M, Tochigi S, Kondoh S, Hirai T, et al: Systemic distribution, nuclear
entry and cytotoxicity of amorphous nanosilica following topical
application. Biomaterials 2011, 32:2713-2724.
12. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M,
Tochigi S, Kondoh S, Hirai T, Akase T, et al: Size-dependent cytotoxic
effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie
2010, 65:199-201.
13. Bohle B, Schwihla H, Hu HZ, Friedl-Hajek R, Sowka S, Ferreira F,
Breiteneder H, Bruijnzeel-Koomen CA, de Weger RA, Mudde GC, et al: Long-
lived Th2 clones specific for seasonal and perennial allergens can be
detected in blood and skin by their TCR-hypervariable regions. J
Immunol 1998, 160:2022-2027.
14. Flohr C, Johansson SG, Wahlgren CF, Williams H: How atopic is atopic
dermatitis? J Allergy Clin Immunol 2004, 114:150-158.
15. Schafer T, Heinrich J, Wjst M, Adam H, Ring J, Wichmann HE: Association
between severity of atopic eczema and degree of sensitization to
aeroallergens in schoolchildren. J Allergy Clin Immunol 1999,
104:1280-1284.
16. Bieber T: Atopic dermatitis. Ann Dermatol 2010, 22:125-137.
17. Plotz SG, Ring J: What’s new in atopic eczema? Expert Opin Emerg Drugs
2010, 15:249-267.
18. Annesi-Maesano I, Caillaud D, Lavaud F, Moreau D, Le Moullec Y, Taytard A,
Pauli G, Charpin D: Exposure to fine air particles and occurrence of
allergic diseases: results of ISAAC-France phase 2. Arch Pediatr 2009,
16:299-305.
19. Annesi-Maesano I, Moreau D, Caillaud D, Lavaud F, Le Moullec Y, Taytard A,
Pauli G, Charpin D: Residential proximity fine particles related to allergic
sensitisation and asthma in primary school children. Respir Med 2007,
101:1721-1729.
20. Yanagisawa R, Takano H, Inoue K, Koike E, Kamachi T, Sadakane K,
Ichinose T: Titanium dioxide nanoparticles aggravate atopic dermatitis-
like skin lesions in NC/Nga mice. Exp Biol Med (Maywood) 2009,
234:314-322.
21. Yanagisawa R, Takano H, Inoue KI, Koike E, Sadakane K, Ichinose T: Size
effects of polystyrene nanoparticles on atopic dermatitislike skin lesions
in NC/NGA mice. Int J Immunopathol Pharmacol 2010, 23:131-141.
22. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y: Mast cells in
atopic dermatitis. Curr Opin Immunol 2009, 21:666-678.
23. Yamashita H, Michibata Y, Mizukami H, Ogihara Y, Morita A, Nose M:
Dermal mast cells play a central role in the incidence of scratching
behavior in mice induced by multiple application of the hapten, 2,4,6-
trinitrochlorobenzene. Exp Dermatol 2005, 14:438-444.
24. Stone KD, Prussin C, Metcalfe DD: IgE, mast cells, basophils, and
eosinophils. J Allergy Clin Immunol 2010, 125:S73-80.
25. Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Uji M, Ichihashi K,
Akase T, Yamashita T, Yamashita K, Nagano K, Abe Y, Kamada H, Tsunoda S,
Yoshioka Y, Itoh N, Tsutsumi Y: Size-dependent immune-modulating
effect of amorphous nanosilica particles. Pharmazie .
26. Tran KK, Shen H: The role of phagosomal pH on the size-dependent
efficiency of cross-presentation by dendritic cells. Biomaterials 2009,
30:1356-1362.
Hirai et al. Particle and Fibre Toxicology 2012, 9:3
http://www.particleandfibretoxicology.com/content/9/1/3
Page 10 of 11
27. Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC: The
relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma
and disease severity in children with atopic dermatitis. Mediators Inflamm
2006, 2006:73098.
28. Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC: Are age-
specific high serum IgE levels associated with worse symptomatology in
children with atopic dermatitis? Int J Dermatol 2007, 46:1258-1262.
29. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ,
Hamid Q: Messenger RNA expression of the cytokine gene cluster,
interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-
stimulating factor, in allergen-induced late-phase cutaneous reactions in
atopic subjects. J Exp Med 1991, 173:775-778.
30. Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chretien I, Briere F,
Pene J, de Vries JE: Shifts in interleukin-4 and interferon-gamma
production by T cells of patients with elevated serum IgE levels and the
modulatory effects of these lymphokines on spontaneous IgE synthesis.
J Allergy Clin Immunol 1991, 87:58-69.
31. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights
into atopic dermatitis. J Clin Invest 2004, 113:651-657.
32. Liu FT, Goodarzi H, Chen HY: IgE, Mast Cells, and Eosinophils in Atopic
Dermatitis. Clin Rev Allergy Immunol 2011.
33. Elias PM, Steinhoff M: “Outside-to-inside” (and now back to “outside”)
pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008,
128:1067-1070.
34. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K,
Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, et al: IL-18 contributes to
the spontaneous development of atopic dermatitis-like inflammatory
skin lesion independently of IgE/stat6 under specific pathogen-free
conditions. Proc Natl Acad Sci USA 2002, 99:11340-11345.
35. Ziegler SF, Artis D: Sensing the outside world: TSLP regulates barrier
immunity. Nat Immunol 2010, 11:289-293.
36. Terada M, Tsutsui H, Imai Y, Yasuda K, Mizutani H, Yamanishi K, Kubo M,
Matsui K, Sano H, Nakanishi K: Contribution of IL-18 to atopic-dermatitis-
like skin inflammation induced by Staphylococcus aureus product in
mice. Proc Natl Acad Sci USA 2006, 103:8816-8821.
37. Yoshimoto T, Min B, Sugimoto T, Hayashi N, Ishikawa Y, Sasaki Y, Hata H,
Takeda K, Okumura K, Van Kaer L, et al: Nonredundant roles for CD1d-
restricted natural killer T cells and conventional CD4+ T cells in the
induction of immunoglobulin E antibodies in response to interleukin 18
treatment of mice. J Exp Med 2003, 197:997-1005.
38. Yoshimoto T, Nakanishi K: Roles of IL-18 in basophils and mast cells.
Allergol Int 2006, 55:105-113.
39. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S,
Paul WE, Nakanishi K: IL-18, although antiallergic when administered with
IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad
Sci USA 1999, 96:13962-13966.
40. Fang C, Siew LQ, Corrigan CJ, Ying S: The role of thymic stromal
lymphopoietin in allergic inflammation and chronic obstructive
pulmonary disease. Arch Immunol Ther Exp (Warsz) 2010, 58:81-90.
doi:10.1186/1743-8977-9-3
Cite this article as: Hirai et al.: Amorphous silica nanoparticles size-
dependently aggravate atopic dermatitis-like skin lesions following an
intradermal injection. Particle and Fibre Toxicology 2012 9:3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hirai et al. Particle and Fibre Toxicology 2012, 9:3
http://www.particleandfibretoxicology.com/content/9/1/3
Page 11 of 11
